Cetera Investment Advisers
DNA icon

Cetera Investment Advisers’s Ginkgo Bioworks DNA Stock Holding History

Cetera Investment Advisers’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,843
Closed -$64.8K – 3778
2024
Q2 		$64.8K Sell
4,843
-51,760
-91% -$1.54M ﹤0.01% 3570
2024
Q1 		$2.63M Buy
56,603
+54,570
+2,684% +$2.82M 0.01% 1364
2023
Q4 		$137K Buy
2,033
+889
+78% +$54.4K ﹤0.01% 2107
2023
Q3 		$82.8K Buy
1,144
+204
+22% +$16.3K ﹤0.01% 2111
2023
Q2 		$70K Sell
940
-359
-28% -$21.3K ﹤0.01% 2109
2023
Q1 		$69.1K Buy
1,299
+408
+46% +$25.9K ﹤0.01% 2081
2022
Q4 		$60.2K Sell
891
-407
-31% -$37.4K ﹤0.01% 2030
2022
Q3 		$162K Buy
1,298
+952
+275% +$113K ﹤0.01% 1526
2022
Q2 		$33K Buy
+346
New +$42.2K ﹤0.01% 1786

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return